Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Asthma Med Recalled
04/14/2023
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network

Advertisement

News
California Bill Would Mandate HPV Vaccine for Incoming College Students
04/12/2023
Lawmakers in California are considering legislation that would require schools to notify parents that their children are expected to receive the HPV vaccine prior to entering eighth grade.
Lawmakers in California are considering legislation that would require schools to notify parents that their children are expected to receive the HPV vaccine prior to entering eighth grade.
Lawmakers in California are...
04/12/2023
Pharmacy Learning Network
News
Diabetes Drug Tablets Recalled
04/05/2023
Several strengths of glimepiride tablets have been issued a Class II recall for deviations from Current Good Manufacturing Practices.
Several strengths of glimepiride tablets have been issued a Class II recall for deviations from Current Good Manufacturing Practices.
Several strengths of glimepiride...
04/05/2023
Pharmacy Learning Network
News
Osteoporosis Medication Recalled
04/05/2023
A Class II recall has been issued for over 370,000 bottles of calcitonin salmon nasal spray due to being out of specification for impurities.
A Class II recall has been issued for over 370,000 bottles of calcitonin salmon nasal spray due to being out of specification for impurities.
A Class II recall has been...
04/05/2023
Pharmacy Learning Network

Advertisement

News
Statin Recalled
04/05/2023
A Class II recall has been issued for simvastatin tablets due to deviations from due to deviations from Current Good Manufacturing Practices.
A Class II recall has been issued for simvastatin tablets due to deviations from due to deviations from Current Good Manufacturing Practices.
A Class II recall has been...
04/05/2023
Pharmacy Learning Network
News
RSV Vaccine Efficacious for Older Adults Regardless of Underlying Conditions
03/31/2023
Data from an ongoing phase 3 trial suggest a vaccine for respiratory syncytial virus is efficacious for preventing infection and severe disease in older adults.
Data from an ongoing phase 3 trial suggest a vaccine for respiratory syncytial virus is efficacious for preventing infection and severe disease in older adults.
Data from an ongoing phase 3...
03/31/2023
First Report Managed Care
News
ADHD Patches Recalled
03/30/2023
A Class II recall has been issued for methylphenidate transdermal system patches due to defective delivery systems.
A Class II recall has been issued for methylphenidate transdermal system patches due to defective delivery systems.
A Class II recall has been...
03/30/2023
Pharmacy Learning Network

Advertisement

News
RSV Vaccination in Older Adults Could Significantly Reduce Disease Burden, Model Suggests
03/29/2023
Researchers modeled the epidemiology of respiratory syncytial virus in the United States and advised vaccination for older adults could reduce both the burden of disease and transmissibility to other age groups. 
Researchers modeled the epidemiology of respiratory syncytial virus in the United States and advised vaccination for older adults could reduce both the burden of disease and transmissibility to other age groups. 
Researchers modeled the...
03/29/2023
First Report Managed Care
News
OTC Eye Solution Recalled
03/24/2023
A class II recall has been issued for more than 700,000 lots of OTC eye solution for failing to meet impurities specifications.
A class II recall has been issued for more than 700,000 lots of OTC eye solution for failing to meet impurities specifications.
A class II recall has been...
03/24/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use